Skip to contentR
Rigel Pharmaceuticals Inc
R
RIGLRigel Pharmaceuticals Inc Released Nov 4, 2014, during market hours
10-Q filed Nov 4, 2014, 35 days after period end · 0001104659-14-076408
Q3 2014 · 10-Q
Revenue—
Net income—
EPS Diluted-$0.24-$0.24N/M vs Q3 2013 No earnings release is on file for this quarter. Its figures came with the 10-Q.
The same fiscal quarter, prior years. Thaler holds no estimates to compare against.
Rigel Pharmaceuticals Inc · CIK 1034842 · Engraved from SEC EDGAR
N/M vs Q2 2014
Operating Income-$21,040,000N/M Operating Cash Flowderived-$18,331,000N/M Free Cash Flowderived-$18,337,000N/M ended Sep 30, 2014 · filed Nov 4, 2014 · 35 d after period end
1.5% from the close of Nov 3, 2014 to the close of Nov 4, 2014, the first after the release.
during market hours$1.96$1.93 Oct 8Nov 4Dec 4